Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter]

Jessica L. Dunne, Sarah J. Richardson, Mark A. Atkinson, Maria E. Craig, Knut Dahl-Jørgensen, Malin Flodström-Tullberg, Heikki Hyöty, Richard E. Lloyd, Noel G. Morgan, Alberto Pugliese

Research output: Contribution to journalLetter

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)1100-1103
Number of pages4
JournalDiabetologia
Volume62
Issue number6
DOIs
StatePublished - Jun 1 2019

Keywords

  • Antiviral agents
  • Clinical trials
  • DiViD
  • Enterovirus
  • Islet
  • nPOD

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Dunne, J. L., Richardson, S. J., Atkinson, M. A., Craig, M. E., Dahl-Jørgensen, K., Flodström-Tullberg, M., Hyöty, H., Lloyd, R. E., Morgan, N. G., & Pugliese, A. (2019). Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter]. Diabetologia, 62(6), 1100-1103. https://doi.org/10.1007/s00125-019-4873-6